Biotech Archives - Page 90 of 795

2 minute read

What’s Going On European Pharma Giant AstraZeneca Stock On Wednesday?

March 27, 1:42 PM

Japan approves AstraZeneca & Sanofi's Beyfortus for respiratory syncytial virus in neonates, infants, & children. Also, Truqap receives approval for unresectable or recurrent breast cancer. AstraZeneca challenges Arkansas law extending drug discounts to for-profit pharmacy chains, citing federal regulations."

AZN

2 minute read

The Most Important Catalyst For Merck’s Stock In 2024 Could Be Sotatercept Launch, Analyst Says

By Vandana Singh

March 27, 1:37 PM

Cantor Fitzgerald notes Merck's robust stock performance, up 15% YTD vs S&P 500's 10%.Potential peak sales projections ranging from $1 billion to $8 billion. Merck targets 40,000 potential patients.

MRK

2 minute read

Podcast: LSD ‘Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics’ Says MindMed’s R. Barrow

By Lara Goldstein

March 27, 10:25 AM

Welcome to a new episode of the Benzinga Psychedelics Podcast where we’re joined by Robert Barrow, CEO of…

MNMD

1 minute read

Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows

By Vandana Singh

March 27, 10:16 AM

Novocure's Phase 3 METIS trial results: TTFields therapy, combined with supportive care, significantly prolongs time to intracranial progression for NSCLC brain metastases patients compared to supportive care alone

NVCR

2 minute read

Micro-Cap Stock iBio Doubles On Wednesday – Here’s Why

By Vandana Singh

March 27, 10:04 AM

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares soared over 100%, hitting $2.44. Collaboration aims to target TGFb superfamily for muscle wasting & obesity treatment.

IBIO

2 minute read

Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?

By Vandana Singh

March 27, 9:31 AM

Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipose tissue, and results in obesity and Metabolic dysfunction-associated steatohepatitis trials.

ALT

4 minute read

Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Extension In Time To Intracranial Progression For Patients With Brain Metastases From Non-Small Cell Lung Cancer

By Benzinga Newsdesk

March 27, 9:30 AM

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive care compared to 11.3 months for patients treated with supportive care

NVCR

3 minute read

Aerovate Therapeutics To Present Patient Baseline Characteristics Of The Phase 2b Portion Of The Phase 2b/Phase 3 IMPAHCT Trial At The American Thoracic Society 2024 International Conference

By Benzinga Newsdesk

March 27, 9:28 AM

Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease, today announced an upcoming poster

AVTE

2 minute read

Merck’s $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease

By Vandana Singh

March 27, 9:20 AM

FDA approves Merck's Winrevair for PAH treatment. First-in-class therapy to enhance exercise capacity, improve WHO FC, and reduce clinical worsening. Available in select U.S. pharmacies by April. Pricing details revealed.

BMY

3 minute read

GRAIL Presents New Data On Galleri And Its Methylation Platform At The Annual American Association For Cancer Research Meeting

By Benzinga Newsdesk

March 27, 9:03 AM

New Data Will Highlight Use of GRAIL's Targeted Methylation Platform Across Early Cancer Detection and Precision OncologyLonger-term Data Underscore the Potential Value of GRAIL's Galleri® for Repeat Screening for

ILMN